Barrie Urology Associates Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01381120
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Barrie Urology Associates - The Male/Female Health and Research Centre

Active Ingredients

Drugs in Phase 4 Trials (3)

acetaminophen (tylenol) (1 trial)

oxycodone (oxycontin) (1 trial)

solifenacin (vesicare) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Flank Pain (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3